Bye Bye HIV. Thailand is the first country to achieve this with innovation developed by Thai researchers.
Bye Bye HIV for people who had taken antiretrovirals
Bye Bye HIV for people who have never used antiretrovirals
Play Video
กลไกลการทำงานของ นวัตกรรม ByeBye HIV
1. 20 cases with increased CD4
Results of APCO’s program to increase CD4 to recover from AIDS
Bye Bye HIV innovation stimulates the production of Th1 and Th17 white blood cells,
leading to a rapid increase in CD4 in infected individuals until they recover from AIDS.
0
%
Th17 increases
0
%
Th1 increases
Th1 and Th17 white blood cells work together to stimulate Killer T cells.
+
2. APCO Immunotherapy rapidly reduces HIV viral load
Mr Kan
Before using Bye Bye HIV innovation HIV Viral Load (VL) 1,741,016
After using Bye Bye HIV innovation for 15 days VL decreased from 1,741,016 to 183 copies/ml
Mr. Jay
Before using Bye Bye HIV innovation HIV Viral Load (VL) 3,996,695
After using Bye Bye HIV innovation for 30 days VL decreased from 3,996,695 to 2,637,861 copies/ml
Mr. Poom
Before using Bye Bye HIV innovation HIV Viral Load (VL) 4,444,489
After using Bye Bye HIV innovation for 30 days VL decreased from 4,444,489 to 60,906 copies/ml
How does a Killer T cell work?
3. ทำให้เกิดการเสริมสร้าง Telomere อย่างมีประสิทธิภาพ
นวัตกรรม Bye Bye HIV จึงลดผลข้างเคียงทั้งหลายจากยาต้านไวรัส
